TECSANTE offers a new vision of health technologies by bringing together actors in the health sector from all over the region (Universities, Engineering Schools, organizations, CHU, CIC-IT, Medtech companies) and covers the entire path of the medical device or drugs, from the idea (clinical need) to the market. Based on the needs expressed by clinicians and patients, the project implements the concept of "personalized health" and aims to accelerate the development of new technological tools that integrate with personalized therapeutic strategies. This operation has three objectives: 1) Acquire equipment for the TECSANTE platform and more specifically on the CONCEPTION axes for the MTI and I3D technical platforms and MODELISATION for the Microfluidic technical platform (UTC), 2) Recruit 2 Engineers for the Design (MTI) and Evaluation (E-health) axes, 3) Launch 6 research projects selected upstream (involvement of at least 2 CPER laboratories, (applied research and high recovery potential, use of the platform's equipment) and financing of 6 engineers, the operation will be financed from the laboratories' own funds and via regional co-financing. These projects aim to develop new health technologies using the TECSANTE platform and the 6 technical platforms (I3D, MTI, Spidermass, Esante, μFluidique, Tissue Engineering).